A trithiol bifunctional chelate for 72,77As: A matched pair theranostic complex with high in vivo stability
- Univ. of Missouri, Columbia, MO (United States). Dept. of Chemistry
- Univ. of Missouri, Columbia, MO (United States). Dept. of Chemistry; Brookhaven National Lab. (BNL), Upton, NY (United States). Medical Isotope Research and Production Program (MIRP). Collider-Accelerator Dept.
- Harry S. Truman Memorial Veterans' Hospital, Columbia, MO (United States). Research Service
- Univ. of Missouri, Columbia, MO (United States). Molecular Interaction Core
- Univ. of Missouri, Columbia, MO (United States). Research Reactor Center (MURR); Brookhaven National Lab. (BNL), Upton, NY (United States). Medical Isotope Research and Production Program (MIRP). Collider-Accelerator Dept.
- Univ. of Missouri, Columbia, MO (United States). Research Reactor Center (MURR)
- Univ. of Missouri, Columbia, MO (United States). Dept. of Chemistry. Research Reactor Center (MURR)
Trithiol chelates are suitable for labeling radioarsenic (72As: 2.49 MeV β+, 26 h; 77As: 0.683 MeV β-, 38.8 h) to form potential theranostic radiopharmaceuticals for PET imaging and therapy. In this paper, to investigate the in vivo stability of trithiol chelates complexed with no carrier added (nca) radioarsenic, a bifunctional trithiol chelate was developed, and conjugated to bombesin(7–14)NH2 as a model peptide. A trithiol-BBN(7–14)NH2 bioconjugate and its arsenic complex were synthesized and characterized. The trithiol-BBN(7–14)NH2 conjugate was radiolabeled with 77As, its in vitro stability assessed, and biodistribution studies were performed in CF-1 normal mice of free [77As]arsenate and 77As-trithiol- BBN(7–14)NH2. The trithiol-BBN(7–14)NH2 conjugate, its precursors and its As-trithiol-BBN(7–14)NH2 complex were fully characterized. Radiolabeling studies with nca 77As resulted in over 90% radiochemical yield of 77As-trithiol-BBN, which was stable for over 48 h. Biodistribution studies were performed with both free [77As]arsenate and Sep-Pak® purified 77As-trithiol-BBN(7–14)NH2. Compared to the fast renal clearance of free [77As]arsenate, 77As-trithiol-BBN(7–14)NH2 demonstrated increased retention with clearance mainly through the hepatobiliary system, consistent with the lipophilicity of the 77As-trithiol-BBN(714)NH2 complex. Finally, the combined in vitro stability of 77As-trithiol-BBN(7–14)NH2 and the biodistribution results demonstrate its high in vivo stability, making the trithiol a promising platform for developing radioarsenic-based theranostic radiopharmaceuticals.
- Research Organization:
- Brookhaven National Lab. (BNL), Upton, NY (United States); Univ. of Missouri, Columbia, MO (United States); Harry S. Truman Memorial Veterans' Hospital, Columbia, MO (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC), Nuclear Physics (NP); National Inst. of Health (NIH) (United States); Dept. of Veterans Affairs (VA) (United States)
- Grant/Contract Number:
- SC0012704; SC0003851; SC0010283; 5 T32-EB004822
- OSTI ID:
- 1464108
- Alternate ID(s):
- OSTI ID: 1544917
- Report Number(s):
- BNL-207952-2018-JAAM; TRN: US1902361
- Journal Information:
- Nuclear Medicine and Biology, Vol. 61; ISSN 0969-8051
- Publisher:
- ElsevierCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Web of Science
Similar Records
Intrinsic and Stable Conjugation of Thiolated Mesoporous Silica Nanoparticles with Radioarsenic
High Yield Production and Radiochemical Isolation of Isotopically Pure Arsenic-72 and Novel Radioarsenic Labeling Strategies for the Development of Theranostic Radiopharmaceuticals